The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Antiseizure Medications for Adults With Epilepsy: A Review
Abstract
Importance: Epilepsy affects approximately 65 million people worldwide. Persistent seizures are associated with a 20% to 40% risk of bodily injuries (eg, fractures, burns, concussions) over 12-month follow-up. The primary goal of epilepsy treatment is to eliminate seizures while minimizing adverse effects of antiseizure drugs (ASDs). Observations: An epileptic seizure is defined as a sudden occurrence of transient signs and symptoms caused by abnormal and excessive or synchronous neuronal activity in the brain. Focal and generalized epilepsy are the 2 most frequent types of epilepsy; diagnosis is based on the type of seizures. There are 26 US Food and Drug Administration-approved medications for epilepsy, of which 24 have similar antiseizure efficacy for focal epilepsy and 9 have similar efficacy for generalized epilepsy. The decision to initiate an ASD should be individualized, but should be strongly considered after 2 unprovoked seizures or after 1 unprovoked seizure that occurred during sleep and/or in the presence of epileptiform activity on an electroencephalogram and/or in the presence of a structural lesion on the brain magnetic resonance imaging. The ASDs must be selected based on the seizure and epilepsy types, the epilepsy syndrome, and the adverse effects associated with the drug. For focal epilepsy, oxcarbazepine and lamotrigine are first-line therapy, while levetiracetam can be also considered if there is no history of psychiatric disorder. For generalized epilepsy, the selection of the ASD is based on the type of epilepsy syndrome and the patient's sex, age, and psychiatric history. Seizure freedom is achieved in approximately 60% to 70% of all patients. A total of 25% to 50% of patients also experience neurologic, psychiatric, cognitive, or medical disorders, such as mood, anxiety, and attention deficit disorders and migraines. For these patients, selecting an ASD should consider the presence of these disorders and concomitant use of medications to treat them. ASDs with cytochrome P450 enzyme-inducing properties (eg, carbamazepine, phenytoin) may worsen comorbid coronary and cerebrovascular disease by causing hyperlipidemia and accelerating the metabolism of concomitant drugs used for their treatment. They can also facilitate the development of osteopenia and osteoporosis. Conclusions and Relevance: Epilepsy affects approximately 65 million people worldwide and is associated with increased rates of bodily injuries and mortality when not optimally treated. For focal and generalized epilepsy, selection of ASDs should consider the seizure and epilepsy types and epilepsy syndrome, as well as the patient's age and sex, comorbidities, and potential drug interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ILAE official report: a practical clinical definition of epilepsy
Fisher, R. S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J. H., Elger, C. E., Engel, J., Forsgren, L., French, J. A., Glynn, M., et al. (2014) · Epilepsia · doi:10.1111/epi.12550 · Cited by 6,108
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies
Fiest, K. M., Sauro, K. M., Wiebe, S., Patten, S. B., Kwon, C.-S., Dykeman, J., Pringsheim, T., Lorenzetti, D. L., & Jetté, N. (2017) · Neurology · doi:10.1212/wnl.0000000000003509 · Cited by 1,902
Chen, Z., Brodie, M. J., Liew, D., & Kwan, P. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3949 · Cited by 1,514
Beghi, E. (2020) · Neuroepidemiology · doi:10.1159/000503831 · Cited by 1,452
Mattson, R. H., Cramer, J. A., Collins, J. F., Smith, D. B., Delgado-Escueta, A. V., Browne, T. R., Williamson, P. D., Treiman, D. M., McNamara, J. O., McCutchen, C. B., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507183130303 · Cited by 1,138
Psychiatric comorbidity in epilepsy: a population-based analysis
Tellez‐Zenteno, J. F., Patten, S. B., Jetté, N., Williams, J., & Wiebe, S. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01222.x · Cited by 1,113
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
Semah, F., Picot, M.-C., Adam, C., Broglin, D., Arzimanoglou, A., Bazin, B., Cavalcanti, D., & Baulac, M. (1998) · Neurology · doi:10.1212/wnl.51.5.1256 · Cited by 1,113
Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis
Téllez-Zenteno, J. F., Dhar, R., & Wiebe, S. (2005) · Brain · doi:10.1093/brain/awh449 · Cited by 1,088
Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., Cramp, C., Cockerell, O. C., Cooper, P. N., Doughty, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60460-7 · Cited by 976
Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., Cramp, C., Cockerell, O. C., Cooper, P. N., Doughty, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60461-9 · Cited by 969
Silberstein, S. D., Holland, S., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E. (2012) · Neurology · doi:10.1212/wnl.0b013e3182535d20 · Cited by 897
Meador, K. J., Baker, G. A., Browning, N., Cohen, M. J., Bromley, R. L., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70323-x · Cited by 834
Self-citationTomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., Perucca, E., & Vajda, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70107-7 · Cited by 751
Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention
Devinsky, O., Hesdorffer, D. C., Thurman, D. J., Lhatoo, S., & Richerson, G. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30158-2 · Cited by 721
Mattson, R. H., Cramer, J. A., & Collins, J. F. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209103271104 · Cited by 683
Resective Epilepsy Surgery for Drug-Resistant Focal Epilepsy: A Review
Jobst, B. C., & Cascino, G. D. (2015) · JAMA · doi:10.1001/jama.2014.17426 · Cited by 665
French, J. A., Kanner, A. M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C. L., Theodore, W. H., Bazil, C., Stern, J., Schachter, S. C., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000123693.82339.fc · Cited by 654
Self-citationComparative safety of antiepileptic drugs during pregnancy
Hernández-Díaz, S., Smith, C. R., Shen, A., Mittendorf, R., Hauser, W. A., Yerby, M., Holmes, L. B., For the North American AED Pregnancy Registry, North American AED (Antiepileptic Drug) Pregnancy Registry, Cragan, J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182574f39 · Cited by 620
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
Brodie, M. J., UK Lamotrigine/Carbamazepine Monotherapy Trial Group, Richens, A., & Yuen, A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90581-2 · Cited by 615
Tomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Perucca, E., Sabers, A., Thomas, S. V., Vajda, F., Faravelli, F., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30107-8 · Cited by 544
Englot, D. J., Chang, E. F., & Auguste, K. I. (2011) · Journal of Neurosurgery · doi:10.3171/2011.7.jns11977 · Cited by 514
(2006) · Annals of Neurology · doi:10.1002/(issn)1531-8249 · Cited by 513
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy
Brodie, M. J., Perucca, E., Ryvlin, P., Ben-Menachem, E., & Meencke, H.-J. (2007) · Neurology · doi:10.1212/01.wnl.0000252941.50833.4a · Cited by 467
Brodie, M. J., Overstall, P. W., & Giorgi, L. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(99)00039-x · Cited by 459
Management of psychiatric and neurological comorbidities in epilepsy
Kanner, A. M. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.243 · Cited by 451
Self-citation(2009) · Neurology · doi:10.1212/wnl.0b013e3181a6b312 · Cited by 428
French, J. A., Kanner, A. M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C. L., Theodore, W. H., Bazil, C., Stern, J., Schachter, S. C., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000123695.22623.32 · Cited by 407
Self-citationRisk of Stevens–Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics
Mockenhaupt, M., Messenheimer, J., Tennis, P., & Schlingmann, J. (2005) · Neurology · doi:10.1212/01.wnl.0000156354.20227.f0 · Cited by 399
Mogens Dam (Chairman), R. E. (1989) · Epilepsy Research · doi:10.1016/0920-1211(89)90070-3 · Cited by 393
Effect of antiepileptic drugs on bone density in ambulatory patients
Farhat, G., Yamout, B., Mikati, M. A., Demirjian, S., Sawaya, R., & El-Hajj Fuleihan, G. (2002) · Neurology · doi:10.1212/wnl.58.9.1348 · Cited by 358
Randomised study of antiepileptic drug withdrawal in patients in remission
MEDICALRESEARCHCOUNCILANTIEPILE (1991) · The Lancet · doi:10.1016/0140-6736(91)92856-w · Cited by 354
Krumholz, A., Wiebe, S., Gronseth, G. S., Gloss, D. S., Sanchez, A. M., Kabir, A. A., Liferidge, A. T., Martello, J. P., Kanner, A. M., Shinnar, S., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001487 · Cited by 343
Self-citationKim, L. G., Johnson, T. L., Marson, A. G., & Chadwick, D. W. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70383-0 · Cited by 320
Harden, C. L., Pennell, P. B., Koppel, B. S., Hovinga, C. A., Gidal, B., Meador, K. J., Hopp, J., Ting, T. Y., Hauser, W. A., Thurman, D., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a6b325 · Cited by 307
Relapse following discontinuation of antiepileptic drugs: A meta‐analysis
Berg, A. T., & Shinnar, S. (1994) · Neurology · doi:10.1212/wnl.44.4.601 · Cited by 294
Campbell, E., Kennedy, F., Russell, A., Smithson, W. H., Parsons, L., Morrison, P. J., Liggan, B., Irwin, B., Delanty, N., Hunt, S. J., et al. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306318 · Cited by 292
Lamberink, H. J., Otte, W. M., Geerts, A. T., Pavlovic, M., Ramos-Lizana, J., Marson, A. G., Overweg, J., Sauma, L., Specchio, L. M., Tennison, M., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30114-x · Cited by 279
Teratogenic effects of antiepileptic drugs
Tomson, T., & Battino, D. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70103-5 · Cited by 271
Guerreiro, M. M., Vigonius, U., Pohlmann, H., de Manreza, M. L. G., Fejerman, N., Antoniuk, S. A., & Moore, A. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00025-9 · Cited by 241
Marson, A., Burnside, G., Appleton, R., Smith, D., Leach, J. P., Sills, G., Tudur-Smith, C., Plumpton, C., Hughes, D. A., Williamson, P., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00246-4 · Cited by 219
Christe, W., Krämer, G., Vigonius, U., Pohlmann, H., Steinhoff, B. J., Brodie, M. J., & Moore, A. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(96)01013-3 · Cited by 216
Bill, P. A., Vigonius, U., Pohlmann, H., Guerreiro, C. A. M., Kochen, S., Saffer, D., & Moore, A. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00024-7 · Cited by 216
Marson, A., Burnside, G., Appleton, R., Smith, D., Leach, J. P., Sills, G., Tudur-Smith, C., Plumpton, C., Hughes, D. A., Williamson, P., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00247-6 · Cited by 208
Weight issues for people with epilepsy—A review
Ben‐Menachem, E. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01402.x · Cited by 206
Baulac, M., Brodie, M. J., Patten, A., Segieth, J., & Giorgi, L. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70105-9 · Cited by 186
Nonepileptic seizures: an updated review
Perez, D. L., & LaFrance, W. C. (2016) · CNS Spectrums · doi:10.1017/s109285291600002x · Cited by 177
Baulac, M., Rosenow, F., Toledo, M., Terada, K., Li, T., De Backer, M., Werhahn, K. J., & Brock, M. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30292-7 · Cited by 165
Tatum, W. O., Hirsch, L. J., Gelfand, M. A., Acton, E. K., LaFrance, W. C., Jr., Duckrow, R. B., Chen, D. K., Blum, A. S., Hixson, J., Drazkowski, J., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4785 · Cited by 155
Frequency of a false positive diagnosis of epilepsy: A systematic review of observational studies
Xu, Y. H., Nguyen, D. C., Mohamed, A., Carcel, C., Li, Q., Kutlubaev, M. A., Anderson, C. S., & Hackett, M. L. (2016) · Seizure · doi:10.1016/j.seizure.2016.08.005 · Cited by 149
Seizure clusters: characteristics and treatment
Haut, S. R. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000177 · Cited by 147
Veiby, G., Engelsen, B. A., & Gilhus, N. E. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4290 · Cited by 138
Long-term prognosis for childhood and juvenile absence epilepsy
Trinka, E., Baumgartner, S., Unterberger, I., Unterrainer, J. M., Luef, G. J., Haberlandt, E., & Bauer, G. J. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0521-1 · Cited by 136
Epilepsy in the UK: Misdiagnosis, mistreatment, and undertreatment?
Leach, J. P., Lauder, R., Nicolson, A., & Smith, D. (2005) · Seizure · doi:10.1016/j.seizure.2005.08.008 · Cited by 136
Mula, M., Trimble, M., & Sander, J. W. A. S. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01262.x · Cited by 123
Carbone, L. D., Johnson, K., Robbins, J. A., Larson, J. C., Curb, J. D., Watson, K. C., Gass, M. L. S., & LaCroix, A. Z. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091027 · Cited by 123
Prognosis of juvenile myoclonic epilepsy 45 years after onset
Senf, P., Schmitz, B., Holtkamp, M., & Janz, D. (2013) · Neurology · doi:10.1212/01.wnl.0000437303.36064.f8 · Cited by 116
Gabapentin versus Lamotrigine Monotherapy: A Double‐blind Comparison in Newly Diagnosed Epilepsy
Brodie, M. J., Chadwick, D. W., Anhut, H., Otte, A., Messmer, S., Maton, S., Sauermann, W., Murray, G., Garofalo, E. A., & for the Gabapentin Study Group 945‐212 (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.45401.x · Cited by 110
Discontinuing antiepileptic drugs in patients who are seizure free on monotherapy
Specchio, L. M. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.1.22 · Cited by 108
Chang, C., Liao, C.-H., Lin, C., Lane, H., Sung, F., & Kao, C.-H. (2014) · Seizure · doi:10.1016/j.seizure.2014.02.007 · Cited by 107
Assessment of potential drug interactions in patients with epilepsy: Impact of age and sex
Gidal, B. E., French, J. A., Grossman, P., & Teuff, G. L. (2009) · Neurology · doi:10.1212/01.wnl.0000341789.77291.8d · Cited by 101
CAMFIELD, P. R., & Camfield, C. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.02.014 · Cited by 96
Kwan, P., Brodie, M. J., Kälviäinen, R. K., Yurkewicz, L., Weaver, J., & Knapp, L. E. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70154-5 · Cited by 88
Association of Enzyme-Inducing Antiseizure Drug Use With Long-term Cardiovascular Disease
Josephson, C. B., Wiebe, S., Delgado‐García, G. R., González-Izquierdo, A., Denaxas, S., Sajobi, T. T., Lamidi, M., Wang, M., & Keezer, M. R. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.3424 · Cited by 87
Fertility and Birth Outcomes in Women With Epilepsy Seeking Pregnancy
Pennell, P. B., French, J. A., Harden, C. L., Davis, A. R., Bagiella, E., Andreopoulos, E., Lau, C., Llewellyn, N., Barnard, S. N., & Allien, S. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0646 · Cited by 86
Kanner, A. M., Ashman, E. J., Gloss, D. S., Harden, C. L., Bourgeois, B. F. D., Bautista, J. F., Abou-Khalil, B. W., Burakgazi-Dalkilic, E., Park, E. L., Stern, J. M., et al. (2018) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7597.18.4.260 · Cited by 81
Self-citationUse of Antiepileptic Drugs During Pregnancy: Evolving Concepts
Pennell, P. B. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0464-0 · Cited by 68
Antiseizure medication use during pregnancy and risk of ASD and ADHD in children
Wiggs, K. K., Rickert, M. E., Sujan, A. C., Quinn, P. D., Larsson, H., Lichtenstein, P., Öberg, A. S., & D'Onofrio, B. M. (2020) · Neurology · doi:10.1212/wnl.0000000000010993 · Cited by 68
Kanner, A. M., Ashman, E. J., Gloss, D. S., Harden, C. L., Bourgeois, B. F. D., Bautista, J. F., Abou-Khalil, B. W., Burakgazi-Dalkilic, E., Park, E. L., Stern, J. M., et al. (2018) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7597.18.4.269 · Cited by 66
Self-citationUnderstanding juvenile myoclonic epilepsy: Contributions from neuroimaging
Anderson, J., & Hamandi, K. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.03.008 · Cited by 57
Bone disease during chronic antiepileptic drug therapy: General versus specific risk factors
Beerhorst, K., van der Kruijs, S. J. M., Verschuure, P., Tan, F. I. Y., & Aldenkamp, A. P. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.05.005 · Cited by 44
Hospital-Onset Seizures: An Inpatient Study
Fields, M. C., Labovitz, D., & French, J. A. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.337 · Cited by 42
New Non-Intravenous Routes for Benzodiazepines in Epilepsy: A Clinician Perspective
Mula, M. (2016) · CNS Drugs · doi:10.1007/s40263-016-0398-4 · Cited by 32
Cited by
Talwar, A., Estes, E., Aparasu, R., & Reddy, D. S. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114238 · Cited by 66
Metadata
- Authors
- Kanner, A. M., & Bicchi, M. M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2022-04-05
- Volume
- 327
- Issue
- 13
- Pages
- 1269
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4224032885
- Cited by
- 447
- References
- 73
- FWCI
- 50.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.